Applied DNA Sciences shares are trading higher after the company announced its COVID-19 diagnostic strategy in response to the emergence of Omicron. The company plans to introduce its Linea 2.0 COVID-19 Assay kit.

by | Nov 29, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.